157 related articles for article (PubMed ID: 22960381)
1. Lysophosphatidic acid: chemical signature of neuropathic pain.
Ueda H; Matsunaga H; Olaposi OI; Nagai J
Biochim Biophys Acta; 2013 Jan; 1831(1):61-73. PubMed ID: 22960381
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.
Velasco M; O'Sullivan C; Sheridan GK
Neuropharmacology; 2017 Feb; 113(Pt B):608-617. PubMed ID: 27059127
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid as the initiator of neuropathic pain.
Ueda H
Biol Pharm Bull; 2011; 34(8):1154-8. PubMed ID: 21804198
[TBL] [Abstract][Full Text] [Related]
4. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H
J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.
Uchida H; Nagai J; Ueda H
Mol Pain; 2014 Nov; 10():71. PubMed ID: 25411045
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.
Inoue M; Ma L; Aoki J; Chun J; Ueda H
Mol Pain; 2008 Feb; 4():6. PubMed ID: 18261210
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of lysophosphatidic acid-induced pain with clinically relevant neuropathic pain drugs.
Ogawa K; Takasu K; Shinohara S; Yoneda Y; Kato A
Eur J Pain; 2012 Aug; 16(7):994-1004. PubMed ID: 22337641
[TBL] [Abstract][Full Text] [Related]
10. LPA-mediated demyelination in ex vivo culture of dorsal root.
Fujita R; Kiguchi N; Ueda H
Neurochem Int; 2007 Jan; 50(2):351-5. PubMed ID: 17056157
[TBL] [Abstract][Full Text] [Related]
11. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
Lin ME; Rivera RR; Chun J
J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
[TBL] [Abstract][Full Text] [Related]
12. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
Santos-Nogueira E; López-Serrano C; Hernández J; Lago N; Astudillo AM; Balsinde J; Estivill-Torrús G; de Fonseca FR; Chun J; López-Vales R
J Neurosci; 2015 Jul; 35(28):10224-35. PubMed ID: 26180199
[TBL] [Abstract][Full Text] [Related]
13. Identification of the sensory nerve fiber responsible for lysophosphatidic acid-induced allodynia in mice.
Ohsawa M; Miyabe Y; Katsu H; Yamamoto S; Ono H
Neuroscience; 2013 Sep; 247():65-74. PubMed ID: 23685168
[TBL] [Abstract][Full Text] [Related]
14. Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain.
Ma L; Nagai J; Ueda H
J Neurochem; 2010 Nov; 115(3):643-53. PubMed ID: 20722972
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice.
López-Serrano C; Santos-Nogueira E; Francos-Quijorna I; Coll-Miró M; Chun J; López-Vales R
Brain Behav Immun; 2019 Feb; 76():258-267. PubMed ID: 30550929
[TBL] [Abstract][Full Text] [Related]
16. An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model.
Ma L; Nagai J; Chun J; Ueda H
Mol Pain; 2013 Jun; 9():29. PubMed ID: 23773289
[TBL] [Abstract][Full Text] [Related]
17. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
Okudaira S; Yukiura H; Aoki J
Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
[TBL] [Abstract][Full Text] [Related]
18. A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord.
Kunori S; Matsumura S; Okuda-Ashitaka E; Katano T; Audoly LP; Urade Y; Ito S
Glia; 2011 Feb; 59(2):208-18. PubMed ID: 21125641
[TBL] [Abstract][Full Text] [Related]
19. Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia.
Uchida H; Matsumoto M; Ueda H
Neurochem Int; 2009; 54(3-4):215-21. PubMed ID: 19111589
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid and signaling in sensory neurons.
Oude Elferink RP; Bolier R; Beuers UH
Biochim Biophys Acta; 2015 Jan; 1851(1):61-5. PubMed ID: 25218302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
